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Abstract 
Background: Shared decision‑making can improve patient satisfaction and outcomes. To participate in shared 
decision‑making, patients need information about the potential risks and benefits of treatment options. Our team has 
developed a novel prototype tool for shared decision‑making called hearts like mine (HLM) that leverages EHR data 
to provide personalized information to patients regarding potential outcomes of different treatments. These poten‑
tial outcomes are presented through an Icon array and/or simulated narratives for each “person” in the display. In this 
pilot project we sought to determine whether the inclusion of simulated narratives in the display affects individuals’ 
decision‑making. Thirty subjects participated in this block‑randomized study in which they used a version of HLM 
with simulated narratives and a version without (or in the opposite order) to make a hypothetical therapeutic deci‑
sion. After each decision, participants completed a questionnaire that measured decisional confidence. We used Chi 
square tests to compare decisions across conditions and Mann–Whitney U tests to examine the effects of narratives 
on decisional confidence. Finally, we calculated the mean of subjects’ post‑experiment rating of whether narratives 
were helpful in their decision‑making.
Results: In this study, there was no effect of simulated narratives on treatment decisions (decision 1: Chi squared = 0, 
p = 1.0; decision 2: Chi squared = 0.574, p = 0.44) or Decisional confidence (decision 1, w = 105.5, p = 0.78; deci‑
sion 2, w = 86.5, p = 0.28). Post‑experiment, participants reported that narratives helped them to make decisions 
(mean = 3.3/4).
Conclusions: We found that simulated narratives had no measurable effect on decisional confidence or decisions 
and most participants felt that the narratives were helpful to them in making therapeutic decisions. The use of simu‑
lated stories holds promise for promoting shared decision‑making while minimizing their potential biasing effect.
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Background
Introduction
Shared decision-making, between patients and phy-
sicians, is an active process which involves mutual 
respect, understanding treatment options, and weighing 
the potential benefits and side effects of those options. 
Shared decision-making is associated with increased 
patient satisfaction, and in some cases, improved health 
outcomes [1]. A variety of resources and tools have been 
developed to facilitate active patient participation in 
shared decision-making (SDM) [2–11]. Decision aids 
have been a particularly successful area of research and 
have been shown to support accurate patient under-
standing of treatment options [12]. State-of-the-art deci-
sion aids calculate personalized outcome probabilities 
and present the results graphically. In many cases deci-
sion aids have been shown to improve patient knowledge, 
patient satisfaction, and decisional conflict [13].
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People learn from different types of experience that 
includes summary statistics and narrative stories. Deci-
sion aids often provide numeric and graphical informa-
tion (paradigmatic information) as well as narratives 
[14]. Research in health communication and health 
promotion has shown that stories are engaging and 
may be more persuasive than statistical information 
[15–18]. Narratives may support information process-
ing in different and potentially deeper ways [19]. How-
ever, inclusion of patient narratives in decisions aids 
may not improve decision-making. In fact, in a recent 
systematic review of patient decision aids, the pres-
ence of narratives was found to have reduced the qual-
ity of patient decision-making [14]. It is worth noting 
that none of the studies analyzed in the review paper 
directly compared narratives vs non-narratives. Most 
decision aids that were examined included multiple 
features but specific information about how narratives 
were implemented was not taken into consideration. 
This is a limitation acknowledged by the authors of the 
review paper. In this pilot study we sought to deter-
mine whether simulated narratives (over which we have 
complete control for future experiments) would affect 
decision-making.
People’s interest in health-related stories is evidenced 
by their behaviors on the Internet. A 2011 Pew Research 
Center report, “The Social Life of Health Information,” 
found that 25 % of adults in the US have read someone 
else’s commentary or experience about health or medi-
cal issues on an online news group, website, or blog [20]. 
While online health information is potentially very valu-
able, it also has its limitations including subjectivity, data 
originating from a non-representative sample, and factual 
inaccuracies that laypeople may not be prepared to criti-
cally evaluate [21]. In addition, by activating the reader’s 
heuristic thinking (e.g. representativeness bias or avail-
ability biases), case studies and anecdotes can bias health 
decisions away from rationality. This effect has been 
observed in both patients and providers [22, 23].
To meet the challenge of generating narratives that are 
both engaging and representative, we are developing a 
novel system called Hearts Like Mine (HLM) that lever-
ages a large clinical data repository to generate simulated 
narratives. The prototype display integrates both natural 
frequencies of outcomes (e.g. 3/100 patients under this 
treatment experienced outcome x) with narratives of 
patients “like you”. HLM retrieves cases demographically 
and clinically similar to the user from the clinical data 
repository and automatically synthesizes patient stories 
based on the retrieved cases. Both the summary statistics 
and synthetic patient stories are displayed in interactive 
icon arrays. This approach integrates the engaging power 
of narratives with the power of big data to help inform 
and engage patients. This paper describes the design of 
HLM, its implementation, and preliminary testing.
Significance
Shared decision-making (SDM) has been called “the pin-
nacle of patient-centered care” and is widely touted as 
an ethical and practical necessity in improving patient 
engagement [24]. SDM is defined as “decisions that are 
shared by doctors and patients, informed by the best evi-
dence available and weighted according to the specific 
characteristics and values of the patient” [25]. A number 
of studies demonstrate that SDM improves outcomes, 
reduces cost, and increases patient and physician sat-
isfaction [13]. The primary tool of SDM is the patient 
decision aid. Patient decision aids have the potential to 
improve knowledge of treatment options, improve the 
accuracy of perceptions of benefits and harms, reduce 
decisional conflict, and increase participation in the deci-
sion-making process [13].
Several research groups have utilized stories to facili-
tate health behavior change. For example, Houston 
et  al. [15] developed a storytelling intervention that 
produced substantial and significant improvements 
in blood pressure rates for African American patients 
with baseline uncontrolled hypertension. Similarly, 
Meissen et  al. found that scenario-based risk infor-
mation messages enhanced perceived susceptibility 
towards contracting a sexually transmitted infection 
[17, 18]. As these studies have shown, stories can affect 
a patient’s decisions about their behavior, therefore it is 
critical that stories are used in a manner appropriate to 
the context [26].
Providing stories that are intended to inform patients 
of different treatment options without biasing them is an 
unexplored area with potential challenges. First, to make 
the stories directly relevant and engaging, they should be 
personalized. Second, to represent the range of outcomes 
associated with each treatment option, a large number of 
stories are required; a sample of one or two stories might 
easily bias patients to a particular choice. Finally, since 
our goal is to develop a tool that efficiently facilitates 
shared decision-making for a variety of medical deci-
sions, manual creation of the stories (as has been done in 
health promotion studies) is not an option.
The emergence of “big clinical data” provides an 
unprecedented opportunity to create representative, 
objective, accurate and personalized narratives. The 
“big data” that enabled our design is a VA-wide medical 
record repository called VINCI (veterans informatics 
and computing infrastructure) [27], which contains data 
for 20 million unique patients. With this large sample, 
it becomes feasible to identify cases similar to almost 
any user. Our approach utilizes both stories and natural 
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frequencies and this combination is intended to be pow-




Hearts like mine is designed with patients (or patient sur-
rogates) as users. It is designed to first match cases to the 
attributes of the patient at hand, then retrieves relevant 
information related to those cases, and finally generates 
stories based on that information and displays the match-
ing stories and natural frequencies for the patient to see. 
Each of the components of the system is described below 
(Fig. 1).
Matching
In this pilot, we selected atrial fibrillation as the use case 
because this disease involves treatment decisions that 
are “preference sensitive”. For example, warfarin and 
dabigatran are similar in terms of their effect on clini-
cal outcomes (i.e. stroke prevention) but involve differ-
ent monitoring schedules (i.e. warfarin requires frequent 
blood testing, dabigatran does not) effects on lifestyle 
(warfarin requires a controlled diet in terms of vitamin 
K, dabigatran does not) and reversibility (anticoagulation 
from dabigatran is irreversible- leading to risk of bleed-
ing in case of accident while warfarin is reversible). Pref-
erence sensitive decisions such as this are particularly in 
need of shared decision-making interventions.
To match participants to others “like you” several clini-
cal variables known to predict bleeding and stroke risks 
in patients with atrial fibrillation were used as matching 
variables [28]. Diagnosis of atrial fibrillation, age, gender, 
hypertension status, diabetes status, and elevated cho-
lesterol level were matched exactly. The patient’s age was 
matched within 5  years. Two variables (smoking status 
and family history) were included in the design but due 
to the need to extract these variables from free text notes, 
the pilot application did not utilize them for matching.
Information retrieval
The prototype limited the outcomes to major adverse 
outcomes, such as death, stroke, heart attack, seri-
ous arrhythmias, kidney failure, and serious bleeding 
events. These outcomes were retrieved from structured 
data tables. Given the prototype nature of the applica-
tion, HLM was not connected to a live database. It used 
canned summary statistics based on literature review and 
domain expert estimations.
Story generation
Typically stories introduce characters, describe conflicts 
and then show resolutions. Automated story generation 
systems often focus on characters and events [29]. We 
designed the patient stories to follow the same general 
form. However, since our goal was to provide users with 
a sufficient number of stories to provide a balanced view 
of potential outcomes and to be able to display relatively 
Fig. 1 HLM architecture
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rare outcomes, we needed to generate a relatively large 
number of stories (e.g. 100). Therefore, each story needed 
to be brief. The number of stories that were provided is 
not the number of stories we expected the patients to 
read. Some patients may read a few stories while others 
may read more.
HLM story templates contained several components: 
(1) person description; (2) treatment/treatment deci-
sion; (3) treatment response regarding symptoms; (4) 
treatment response regarding major outcomes; (5) 
description of specific treatments; and (6) side effects of 
specific treatments. These components were based on 
real patient stories drawn from the EHR and social media 
and designed by a team of two clinicians, a professional 
writer and several informaticians. The clinicians on our 
research team are well versed in the treatment course of 
AF patients. One of the story template authors who had a 
creative writing background spent several weeks brows-
ing and researching a number of AF-related social media 
sites identified using generic Google queries. The goal 
was to identify characteristics of the stories that made 
them particularly engaging. This author reported back 
that the key characteristics are the inclusion of personal 
details and observations (e.g. a name and a hobby can 
make Patient #20 come across more as a real person).
To vary the stories, we also randomly select the com-
ponents to include in a story. Each component has a 20 % 
chance to be omitted from a story. To maintain the logi-
cal flow though, three dependency rules are defined:
  • If a person description is included, it must precede all 
other components;
  • If a treatment/treatment decision is included, it must 
precede treatment responses and side effects;
  • If description of specific treatment is included, it 
must precede treatment responses and side effects.
In addition, the system requires that a story must con-
tain at least 2 components. Most stories generated con-
tain 3–5 components.
The story components were revised interactively 
through several rounds of testing, with 100 sample sto-
ries generated. The team of clinicians, professional writer 
and informaticians read the stories and identified issues, 
e.g. incoherence and lack of transition. The modifications 
are made iteratively until all stories are deemed logical 
and readable by the team.
Display
We designed an interface that allowed users to input their 
own characteristics, select treatments and outcomes of 
interest, and subsequently view a display of natural fre-
quencies of outcomes—accompanied by synthesized 
stories. There are many ways to communicate informa-
tion such as frequencies and risks. The pictograph for-
mat we chose is among the most common and has been 
shown to work well in populations of varying literacy to 
support understanding risks. The interface compared 
common treatment suggestions. Namely, one decision 
involved treatment between two blood-thinning medi-
cations—dabigatran and warfarin. Although both treat-
ments are safe and efficacious, dabigatran is easier to 
administer, requires less monitoring and fewer dietary 
modifications, and carries a risk of irreversible bleeding. 
Warfarin is a medication that has been used for a long 
time, but requires frequent monitoring and attention to 
diet to prevent bleeding. When bleeding does occur with 
warfarin, the effects can be reversed.
The second decision was to treat the arrhythmia (atrial 
fibrillation) and involved the choice of warfarin plus 
the medication amiodorone vs. warfarin plus an abla-
tion procedure. Ablation is a surgical procedure and 
may be an effective treatment but carries risks inherent 
to surgery. Amiodorone is an anti-arrhythmic drug that 
requires monitoring and is associated with infrequent 
but potentially serious side effects. The point of choosing 
these particular decisions is that they are highly sensi-
tive to patient preferences and therefore are particularly 
appropriate for shared decision-making.
HLM implementation
For testing purposes, we implemented two versions of 
HLM; one version with stories and one without. Both 
provide feedback on the natural frequencies of outcomes 
of interest. Our question was whether the version with 
stories might increase engagement and influence deci-
sion-making (Fig. 2).
Preliminary testing
The University of Utah Institutional Review Board 
approved this study. We employed a crossover design in 
which each subject used both versions of the HLM tool 
for two different decision-making scenarios. A sample 
size of 30 was selected because this was a preliminary test 
of HLM to assess feasibility and acceptance of the tech-
nology rather than a clinical trial to assess efficacy. Poten-
tial study participants were approached to participate in 
common areas of the University of Utah Hospital and 
those that agreed were directed to one of two study sta-
tion areas and provided with a University of Utah Insti-
tutional Review Board approved consent cover letter to 
read. When a study participant completed the consent 
cover letter, they were seated at the first study station 
computer of the first available station. Each station con-
sisted of two laptop computers to facilitate the crosso-
ver design. Station one included patient stories in HLM 
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on the first laptop for the first decision and did not have 
patient stories on the second laptop for the second deci-
sion. The second station did not have patient stories in 
HLM for the first decision and included patient stories in 
HLM on the second laptop for the second decision. Fif-
teen study participants completed the study at the first 
station and fifteen study participants completed the study 
at the second station. This allowed for half of the partici-
pants to use the version with the stories first and half the 
participants to use the version without stories first. All 
participants were presented with the same two scenarios 
for decision-making, which are described below (Fig. 3).
Fig. 2 Screen shot of the HLM system
Page 6 of 9Zeng‑Treitler et al. BMC Res Notes  (2016) 9:359 
Decision 1. Study participants started with the first 
laptop and read scenario 1. This scenario described a 
50  year-old patient who had high blood pressure, high 
cholesterol and diabetes who had recently been diag-
nosed with atrial fibrillation. The patient’s symptoms 
were described. Two anticoagulant medications (dabi-
gatran and warfarin) were presented, in a table with 
medication names, benefits, safety risks and clinical 
considerations such as blood and liver tests, frequency 
of dosing, and related dietary and activity restrictions. 
Study subjects were then advised to use the hearts like 
mine tool to conduct further research to evaluate the 
treatment options. When study participants indicated 
that they had sufficient information to select a treatment 
option, they were asked to complete a questionnaire that 
asked which medication they chose followed by 4 ques-
tions regarding the participant’s confidence and ability to 
make the decision using a 4 point Likert-type scale with 
strongly agree scored as 4 and strongly disagree scored as 
1. In the narrative condition, participants were asked to 
answer one additional question regarding the usefulness 
of the stories for decision-making (answered with the 
same Likert-type scale).
Decision 2. Study participants were instructed to move 
from the first laptop to the second laptop. They were then 
provided with scenario 2, which asked the study partici-
pant to assume, regardless of their decision in the first 
scenario, that they had chosen warfarin. They were then 
presented with two treatment options for atrial fibril-
lation: amiodarone  +  warfarin or Ablation  +  warfarin. 
Similarly, to decision 1, a table described the benefits, 
safety risks and factors to consider regarding amiodar-
one and ablation (such as testing, and potential adverse 
effects). Study participants were then asked to use the 
HLM tool to further evaluate the treatment options. 
When study participants indicated that they had suf-
ficient information to select a treatment option, they 
were asked to complete a questionnaire that asked which 
treatment option they chose and the same 4 questions as 
described above.
All study subjects were also asked an additional ques-
tion about the usefulness of the stories. They were asked 
to if they agree with the statement “The individual 
patient stories helped me know which treatment option 
to choose.” using a 4 point Likert-type scale with strongly 
agree scored as 4 and strongly disagree scored as 1.
Study participants were given a $30 gift card and 
thanked for their participation in the study. Participants 
were allowed to complete the tasks in their own time-
frame and they were informed that they could leave the 
experiment at any time. We did not record the amount 
of time each participant took, though on average the par-
ticipants spent 20–30 min. No participants chose to leave 
the study prior to completion.
We used to Chi square tests to compare decisions made 
(decision 1: warfarin vs. dabigatran, decision 2: amiodar-
one vs. ablation) with and without narratives.
We used the non-parametric Mann–Whitney U test 
to examine the effects of narratives on decisional con-
fidence. To conduct this analysis, we first created a 
decisional confidence scale which was the mean of indi-
viduals’ rating form (0—strongly disagree to 4—strongly 
agree) on four statements: “I am certain that I can weigh 
the risks and benefits”; “I am confident that I can make 
a decision between the treatment options”; “I am con-
fident that I can obtain the information I need to make 
an informed decision”; “I am capable of making the best 
treatment decision for my atrial fibrillation”. These ratings 
were made for each decision and comparisons were made 
between individuals across conditions for each decision.
Fig. 3 Illustration of study design
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Finally, we calculated the mean of individuals’ response 
to the question regarding the perceived usefulness of 
narratives.
Results
A total of 30 participants completed the study (Table 1). 
In both versions of the HLM, user confidence in their 
decisions was fairly high with an average score of 3.2/4 
for the questions.
Demographics
In this study we found no difference in the decisions par-
ticipants made when presented with the information with 
or without stories: decision 1: Chi squared = 0, p = 1.0; 
decision 2: Chi squared = 0.574, p = 0.44. Figure 4 pre-
sents the number of individuals who made each decision 
with and without narratives.
Similarly, there was no effect of narrative on par-
ticipants’ decisional confidence (decision 1, w  =  105.5, 
p = 0.78; decision 2, w = 86.5, p = 0.28). Figure 5 pre-
sents subjects’ decisional confidence.
In contrast to our objective findings, participants 
rating of the question “The individual patient stories 
helped me know which treatment option to choose” 
suggested that they felt strongly that narratives helped 
them to make decisions (mean =  3.3/4). Figure 6 pre-
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Fig. 5 Decisional confidence of subjects
Fig. 6 Subjects’ perception on the usefulness of the patient stories
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Discussion and conclusion
In this pilot study we sought to determine whether inclu-
sion of simulated narratives in the presentation of poten-
tial outcomes from a treatment decision would affect 
patients’ therapeutic decision-making. Specifically, partici-
pants used two version of a novel electronic tool to make a 
hypothetical decision. The tool mines EHR data to collect 
information of individuals “like you” who were on different 
treatment regimens, and generates simulated stories about 
those individuals. The system presented these potential 
outcomes as an icon array with or without narratives; we 
measured the decision made and the individuals’ confi-
dence in the decision in both conditions (with and without 
narratives). We found that the inclusion of narratives did 
not affect participants’ treatment decisions, and similarly 
had no effect on ratings of decisional confidence. However, 
after the experiment participants reported that the pres-
ence of simulated stories helped them to make decisions 
and that they were very interested in using the system in 
the future. To the best of our knowledge, the effect of auto-
mated simulated stories on decision-making has not been 
previously studied. Our results suggest that simulated sto-
ries are engaging but did not bias decision-making, which 
has been a problem in other studies [26].
This study is an important initial test of the HLM 
tool to assess the feasibility and acceptance of the 
approach. However, there are some limitations that 
should be noted. The sample size was relatively small. 
Participants were asked to simulate a medical deci-
sion, assessing the risks of a hypothetical treatment 
may have impacted the choices made. Clearly fur-
ther research is needed with participants making 
actual treatment decisions. Another limitation is that 
in this study, participants’ knowledge of treatment 
options under either condition was not tested, this 
could potentially account for differences in cognitive 
processing between the two conditions (story vs. no 
story). Finally, while we provided a large number of 
stories for participants to read (giving them an oppor-
tunity to gain a balanced view of potential outcomes), 
we did not measure the type of stories or the num-
ber of stories that they actually read. To address the 
mechanism by which narratives might affect decision-
making, future studies should either measure actual 
exposure to stories as well as attributes of narratives 
that are believed to affect decision-making (e.g. the 
content and tone of the story) [30]. Finally, the tool 
may not include all features that individuals may con-
sider important. For example, changes in symptoms 
pre and post treatment were not displayed. Similarly 
there are significant cost differences between treat-
ment options, but these were not presented in the 
interface. However, a prior study demonstrates that 
participants do not find cost a compelling reason for 
choosing one treatment over another [31].
In conclusion, HLM shows potential as a useful tool 
to a patient’s participation in shared decision-making. 
Importantly, this tool incorporates narratives in a way 
that harnesses the strengths of narratives, particularly 
patient engagement, but may avoid some of the hazards 
of including only case studies [19, 22]. Additional testing 
in clinical settings that includes baseline measurement of 
knowledge, and preferred decision-making style will be 
a crucial next step. Due to the fact that algorithms auto-
matically extract natural frequencies and generate patient 
stories, Hearts Like Mine represents a scalable approach 
to inform and engage patients in a wide range of treat-
ment or diagnostic decisions.
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